US 7,459,165 B2
	Polypeptides of Pseudomonas aeruginosa
Nathalie Charland, Breakeyville (Canada); Josee Hamel, Sillery (Canada); Bernard Brodeur, Sillery (Canada); Denis Martin, St-Augustin-de-Desmaures (Canada); Isabelle Charlebois, St-Nicolas (Canada); and Diane Bussiere, St-Nicolas (Canada)
Assigned to ID Biomedical Corporation, Laval (Canada)
Appl. No. 10/495,455 PCT Filed Nov. 13, 2002, PCT No. PCT/CA02/01740 § 371(c)(1), (2), (4) Date Nov. 17, 2004, PCT Pub. No. WO03/042240, PCT Pub. Date May 22, 2003.
Claims priority of provisional application 60/331221, filed on Nov. 13, 2001.
Prior Publication US 2005/0107597 A1, May 19, 2005
Int. Cl. A61K 39/104 (2006.01); A61K 39/02 (2006.01); C07K 14/00 (2006.01); C07H 21/04 (2006.01); C12P 21/04 (2006.01)

U.S. Cl. 424—260.1  [424/190.1; 530/300; 530/350; 435/69.1; 435/69.7; 435/252.3; 435/320.1; 536/23.4; 536/23.7; 514/44; 514/459]

10 Claims

1. An isolated polypeptide consisting of the amino acid sequence set forth as SEQ ID NO:4 from which the signal peptide sequence set forth as SEQ ID NO:38 is deleted, wherein the polypeptide is capable of eliciting an immune response in a host to Pseudomonas aeruginosa.